Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neoplasms of the CNS

  Free Subscription


05.02.2024

1 Arch Pathol Lab Med
5 BMC Cancer
1 BMC Neurol
2 Br J Neurosurg
3 Cancer
5 Clin Cancer Res
1 J Natl Cancer Inst
10 J Neurooncol
1 J Neuropathol Exp Neurol
1 J Neurosurg
1 Nat Rev Cancer
6 Neuro Oncol
1 Neurology
1 Neuroradiology
1 PLoS Comput Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Pathol Lab Med

  1. SOOD R, Chatterjee D, Dutta P, Radotra BD, et al
    Transcription Factor Immunohistochemistry in the Classification of Pituitary Neuroendocrine Tumor/Adenoma: Proposal in a Limited-Resource Setting.
    Arch Pathol Lab Med. 2024;148:178-189.
    PubMed         Abstract available


    BMC Cancer

  2. VAN TILBURG CM, Kilburn LB, Perreault S, Schmidt R, et al
    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
    BMC Cancer. 2024;24:147.
    PubMed         Abstract available

  3. ZHANG X, Li Y, Zhang G, Ma C, et al
    Temporal trend in hospitalizations for malignant neoplasm and benign neoplasm: a nationwide study, China, 2004-2020.
    BMC Cancer. 2024;24:154.
    PubMed         Abstract available

  4. YU W, Zhou M, Niu H, Li J, et al
    Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion.
    BMC Cancer. 2024;24:140.
    PubMed         Abstract available

  5. YAO B, Wang H, Wu X, Wang C, et al
    A system review of central nervous system tumors on children in China: epidemiology and clinical characteristics.
    BMC Cancer. 2024;24:138.
    PubMed         Abstract available

  6. HEUER S, Burghaus I, Gose M, Kessler T, et al
    PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
    BMC Cancer. 2024;24:135.
    PubMed         Abstract available


    BMC Neurol

  7. ZHANG L, Zhu L, Ci C, Ai W, et al
    A case of Wilson's disease combined with intracranial lipoma and dysplasia of the corpus callosum with review of the literature.
    BMC Neurol. 2024;24:44.
    PubMed         Abstract available


    Br J Neurosurg

  8. GOEL A
    Letter to the editor - pituitary tumors and diaphragma sellaeRe: Sharifi G, Akbari Dilmaghani N, Sadrhosseini SM, Arastou S. Arachnoid prolapse in endoscopic transsphenoidal surgery of pituitary adenoma, technical note. Br J Neurosurg 2023;37(3):258-6
    Br J Neurosurg. 2023 Oct 27:1. doi: 10.1080/02688697.2023.2273854.
    PubMed        

  9. WANG X, Liao X, Zhang H, Xu Z, et al
    Surgical treating lumbar intraspinal tumor through a para-split laminotomy.
    Br J Neurosurg. 2024;38:45-48.
    PubMed         Abstract available


    Cancer

  10. RANJAN S, Leung D, Ghiaseddin AP, Taylor JW, et al
    Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
    Cancer. 2024 Jan 30. doi: 10.1002/cncr.35220.
    PubMed         Abstract available

  11. LI Y, Cao J, Wang J, Wu W, et al
    Association of the m(6) A reader IGF2BP3 with tumor progression and brain-specific metastasis in breast cancer.
    Cancer. 2023 Oct 20. doi: 10.1002/cncr.35048.
    PubMed         Abstract available

  12. RIEDINGER CJ, Esnakula A, Haight PJ, Suarez AA, et al
    Characterization of mismatch-repair (MMR)/microsatellite instability (MSI)-discordant endometrial cancers.
    Cancer. 2023 Sep 26. doi: 10.1002/cncr.35030.
    PubMed         Abstract available


    Clin Cancer Res

  13. BHATIA A, Moreno R, Reiner AS, Nandakumar S, et al
    Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response.
    Clin Cancer Res. 2024;30:639.
    PubMed        

  14. MANDONNET E
    Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter.
    Clin Cancer Res. 2024;30:638.
    PubMed        

  15. ISER F, Hinz F, Hoffmann DC, Grassl N, et al
    Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma.
    Clin Cancer Res. 2024 Jan 31. doi: 10.1158/1078-0432.CCR-23-2907.
    PubMed         Abstract available

  16. HABASHY KJ, Dmello C, Chen L, Arrieta VA, et al
    Paclitaxel and Carboplatin in Combination with Low-Intensity Pulsed Ultrasound for Glioblastoma.
    Clin Cancer Res. 2024 Jan 31. doi: 10.1158/1078-0432.CCR-23-2367.
    PubMed         Abstract available

  17. FOOTE MB, Argiles G, Rousseau B, Segal NH, et al
    Facts and hopes in colorectal cancer immunotherapy.
    Clin Cancer Res. 2023 Jun 16:CCR-22-2176. doi: 10.1158/1078-0432.CCR-22-2176.
    PubMed         Abstract available


    J Natl Cancer Inst

  18. CHERNG HR, Qu M, Zafari Z, Bentzen S, et al
    Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001.
    J Natl Cancer Inst. 2024 Jan 27:djae020. doi: 10.1093.
    PubMed         Abstract available


    J Neurooncol

  19. TANAKA T, Tamura R, Takei J, Morimoto Y, et al
    An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
    J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-023-04544.
    PubMed         Abstract available

  20. GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
    Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
    J Neurooncol. 2024 Jan 30. doi: 10.1007/s11060-024-04581.
    PubMed        

  21. DASGUPTA P, Rousseau JF
    Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04574.
    PubMed         Abstract available

  22. PETRONEK MS, Bodeker KL, Lee CY, Teferi N, et al
    Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04571.
    PubMed         Abstract available

  23. VAN OPIJNEN MP, Broekman MLD, Cuppen E, Dubbink HJ, et al
    Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04568.
    PubMed         Abstract available

  24. YEKULA A, Gessler DJ, Ferreira C, Shah R, et al
    GammaTile((R)) (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.
    J Neurooncol. 2024 Jan 28. doi: 10.1007/s11060-023-04545.
    PubMed         Abstract available

  25. HESHAM D, On J, Alshahaby N, Amer N, et al
    Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
    J Neurooncol. 2024;166:27-38.
    PubMed         Abstract available

  26. SINGH E, Gurses ME, Costello MC, Lu VM, et al
    Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-024-04582.
    PubMed         Abstract available

  27. WANG B, Liu Y, Zhang J, Yin S, et al
    Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
    J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04583.
    PubMed         Abstract available

  28. HAMMER Y, Najjar W, Kahanov L, Joskowicz L, et al
    Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline.
    J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04580.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  29. KRAUSE KA, Woods JK, Golby AJ, Lee EQ, et al
    Progestin-associated meningiomatosis with unusual schwannoma-like morphology.
    J Neuropathol Exp Neurol. 2024 Feb 1:nlae008. doi: 10.1093.
    PubMed        


    J Neurosurg

  30. ABDULLAHI H
    Letter to the Editor. The association between metastatic brain tumors and brain tumor-related epilepsy.
    J Neurosurg. 2024 Feb 2:1-2. doi: 10.3171/2023.11.JNS232526.
    PubMed        


    Nat Rev Cancer

  31. BREWER G
    Cholesterol-fuelled glioblastoma.
    Nat Rev Cancer. 2024 Jan 31. doi: 10.1038/s41568-024-00672.
    PubMed        


    Neuro Oncol

  32. NELLAN A, Jackson S
    Targeted therapy done right: direct SHH Inhibition for SHH medulloblastoma.
    Neuro Oncol. 2024 Jan 30:noae018. doi: 10.1093.
    PubMed        

  33. GHOSH S, Rothlin CV
    TREM2 function in glioblastoma immune microenvironment: can we distinguish reality from illusion?
    Neuro Oncol. 2024 Jan 30:noae019. doi: 10.1093.
    PubMed        

  34. CHELLIAH A, Wood DA, Canas LS, Shuaib H, et al
    Glioblastoma and Radiotherapy: a multi-center AI study for Survival Predictions from MRI (GRASP study).
    Neuro Oncol. 2024 Jan 29:noae017. doi: 10.1093.
    PubMed         Abstract available

  35. WAITKUS MS, Erman EN, Reitman ZJ, Ashley DM, et al
    Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.
    Neuro Oncol. 2024 Jan 29:noae016. doi: 10.1093.
    PubMed         Abstract available

  36. WANG S, Qi Y, Zhao R, Pan Z, et al
    Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress.
    Neuro Oncol. 2024 Jan 29:noae014. doi: 10.1093.
    PubMed         Abstract available

  37. MACK SC, Bertrand KC
    Understanding the Mechanisms of Diffuse Midline Glioma Cell Migration Towards Therapeutic Targeting.
    Neuro Oncol. 2024 Jan 27:noad263. doi: 10.1093.
    PubMed        


    Neurology

  38. PETERS KB, Templer J, Gerstner ER, Wychowski T, et al
    Discontinuation of Antiseizure Medications in Patients With Brain Tumors.
    Neurology. 2024;102:e209163.
    PubMed         Abstract available


    Neuroradiology

  39. LV K, Hu Y, Cao X, Xie Y, et al
    Altered whole-brain functional network in patients with frontal low-grade gliomas: a resting-state functional MRI study.
    Neuroradiology. 2024 Jan 31. doi: 10.1007/s00234-024-03300.
    PubMed         Abstract available


    PLoS Comput Biol

  40. OCANA-TIENDA B, Leon-Triana O, Perez-Beteta J, Jimenez-Sanchez J, et al
    Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.
    PLoS Comput Biol. 2024;20:e1011400.
    PubMed         Abstract available


    PLoS One

  41. ZECHEL C, Loy M, Wegner C, Dahlke E, et al
    Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    PLoS One. 2024;19:e0291368.
    PubMed         Abstract available

  42. FIVEASH JB, Ye X, Peerboom DM, Mikkelsen T, et al
    Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    PLoS One. 2024;19:e0291128.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.